Singapore markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
21.66-0.08 (-0.37%)
As of 10:15AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-165,947
-167,825
143,403
507,364
214,310
Depreciation & amortisation
25,927
26,143
32,662
11,004
2,962
Deferred income taxes
12,251
7,608
831
-7,840
-1,398
Stock-based compensation
44,175
42,922
32,640
15,882
8,157
Change in working capital
12,542
2,841
2,005
-2,676
-91,451
Accounts receivable
-5,459
2,388
68,638
42,300
-178,480
Accounts payable
-5,286
-6,896
-25,339
-12,206
22,617
Other working capital
17,947
4,796
224,745
514,733
105,498
Other non-cash items
6,328
6,391
4,902
1,139
417
Net cash provided by operating activities
42,176
27,003
253,520
538,577
140,628
Cash flows from investing activities
Investments in property, plant and equipment
-24,229
-22,207
-28,775
-23,844
-35,130
Acquisitions, net
-
-399
-172,679
-61,868
-3,971
Purchases of investments
-543,729
-491,914
-432,982
-730,490
-324,359
Sales/maturities of investments
563,588
552,643
372,710
269,591
37,014
Net cash used for investing activities
-3,934
38,898
-261,314
-546,548
-326,438
Cash flows from financing activities
Debt repayment
-5,664
-4,996
-1,067
-11
0
Common stock issued
-
0
0
89,475
246,190
Common stock repurchased
-25,285
-25,060
-74,337
0
0
Other financing activities
-18,545
-17,732
-1,768
-4,145
-62
Net cash used provided by (used for) financing activities
-49,491
-47,785
-77,141
85,405
261,251
Net change in cash
-11,495
17,967
-85,388
77,468
75,461
Cash at beginning of period
66,172
79,506
164,894
87,426
11,965
Cash at end of period
54,923
97,473
79,506
164,894
87,426
Free cash flow
Operating cash flow
42,176
27,003
253,520
538,577
140,628
Capital expenditure
-24,229
-22,207
-28,775
-23,844
-35,130
Free cash flow
17,947
4,796
224,745
514,733
105,498